ABSI
Price
$2.77
Change
-$0.21 (-7.05%)
Updated
Dec 27 closing price
81 days until earnings call
LCTX
Price
$0.50
Change
-$0.00 (-0.00%)
Updated
Dec 27 closing price
68 days until earnings call
Ad is loading...

ABSI vs LCTX

Header iconABSI vs LCTX Comparison
Open Charts ABSI vs LCTXBanner chart's image
Absci
Price$2.77
Change-$0.21 (-7.05%)
Volume$2.38M
CapitalizationN/A
Lineage Cell Therapeutics
Price$0.50
Change-$0.00 (-0.00%)
Volume$2.17M
CapitalizationN/A
ABSI vs LCTX Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. LCTX commentary
Dec 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and LCTX is a Hold.

COMPARISON
Comparison
Dec 29, 2024
Stock price -- (ABSI: $2.77 vs. LCTX: $0.50)
Brand notoriety: ABSI and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 126% vs. LCTX: 93%
Market capitalization -- ABSI: $318.15M vs. LCTX: $109.55M
ABSI [@Biotechnology] is valued at $318.15M. LCTX’s [@Biotechnology] market capitalization is $109.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABSI and LCTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 3 TA indicator(s) are bullish while LCTX’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 3 bullish, 6 bearish.
  • LCTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -7.36% price change this week, while LCTX (@Biotechnology) price change was -10.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.36%. For the same industry, the average monthly price growth was -1.51%, and the average quarterly price growth was +5.87%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 19, 2025.

LCTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+5.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($318M) has a higher market cap than LCTX($110M). ABSI YTD gains are higher at: -34.048 vs. LCTX (-54.404). LCTX has higher annual earnings (EBITDA): -22.1M vs. ABSI (-83.27M). ABSI has more cash in the bank: 127M vs. LCTX (32.7M). LCTX has less debt than ABSI: LCTX (2.75M) vs ABSI (12M). LCTX has higher revenues than ABSI: LCTX (8.72M) vs ABSI (4.21M).
ABSILCTXABSI / LCTX
Capitalization318M110M289%
EBITDA-83.27M-22.1M377%
Gain YTD-34.048-54.40463%
P/E RatioN/AN/A-
Revenue4.21M8.72M48%
Total Cash127M32.7M388%
Total Debt12M2.75M436%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSILCTX
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 6 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY595.01-6.33
-1.05%
SPDR® S&P 500® ETF Trust
AAPL255.59-3.43
-1.32%
Apple
BTC.X94164.860000-1630.656200
-1.70%
Bitcoin cryptocurrency
GME32.20-0.79
-2.39%
GameStop Corp
TSLA431.66-22.47
-4.95%
Tesla

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-7.05%
BEAM - ABSI
48%
Loosely correlated
-7.35%
CRSP - ABSI
47%
Loosely correlated
-2.56%
PRME - ABSI
46%
Loosely correlated
-1.36%
KYMR - ABSI
45%
Loosely correlated
-4.55%
PLRX - ABSI
45%
Loosely correlated
-3.35%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with GBIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-1.58%
GBIO - LCTX
35%
Loosely correlated
-3.60%
MGTX - LCTX
34%
Loosely correlated
+1.64%
APTO - LCTX
33%
Loosely correlated
-3.87%
NTLA - LCTX
32%
Poorly correlated
-1.24%
ABSI - LCTX
30%
Poorly correlated
-7.05%
More